Aspalathin, a dihydrochalcone C‐glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis
Scope Energy deprivation in the myocardium is associated with impaired heart function. This
study aims to investigate if aspalathin (ASP) can ameliorate hyperglycemic‐induced shift in …
study aims to investigate if aspalathin (ASP) can ameliorate hyperglycemic‐induced shift in …
[HTML][HTML] The transcription profile unveils the cardio-protective effect of aspalathin against lipid toxicity in an in vitro H9c2 model
Aspalathin, a C-glucosyl dihydrochalcone, has previously been shown to protect
cardiomyocytes against hyperglycemia-induced shifts in substrate preference and …
cardiomyocytes against hyperglycemia-induced shifts in substrate preference and …
Phenylpyruvic acid-2-O-β-D-glucoside attenuates high glucose-induced apoptosis in H9c2 cardiomyocytes
PV Dludla, CJF Muller, E Joubert, J Louw… - Planta …, 2016 - thieme-connect.com
Chronic hyperglycemia is closely associated with impaired substrate metabolism,
dysregulated mitochondrial membrane potential, and apoptosis in the diabetic heart. As …
dysregulated mitochondrial membrane potential, and apoptosis in the diabetic heart. As …
[HTML][HTML] Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression
Aspalathin (ASP) can protect H9c2 cardiomyocytes against high glucose (HG)-induced shifts
in myocardial substrate preference, oxidative stress, and apoptosis. The protective …
in myocardial substrate preference, oxidative stress, and apoptosis. The protective …
Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucose-induced injury
CY Chan, MC Mong, WH Liu, CY Huang… - Free radical …, 2014 - Taylor & Francis
H9c2 cardiomyoblast cell line was used to examine the protection of three triterpenes,
asiatic acid, boswellic acid, and oleanolic acid, at 5 or 10 μM against high-glucose-induced …
asiatic acid, boswellic acid, and oleanolic acid, at 5 or 10 μM against high-glucose-induced …
Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model
J Ni, Y Li, Y Xu, R Guo - Phytomedicine, 2021 - Elsevier
Background Diabetic cardiomyopathy is characterized by both systolic and diastolic
dysfunction due to decreased contractility, as well as reduced compliance of the …
dysfunction due to decreased contractility, as well as reduced compliance of the …
Chikusetsu saponin IVa regulates glucose uptake and fatty acid oxidation: implications in antihyperglycemic and hypolipidemic effects
Y Li, T Zhang, J Cui, N Jia, Y Wu, M Xi… - Journal of Pharmacy …, 2015 - academic.oup.com
Objectives The aim of this study is to investigate antidiabetic effects and molecular
mechanisms of the chemical Chikusetsu saponin IVa (CHS) that isolated from root bark of A …
mechanisms of the chemical Chikusetsu saponin IVa (CHS) that isolated from root bark of A …
[HTML][HTML] Myocardial glucose clearance by aspalathin treatment in young, mature, and obese insulin-resistant rats
SE Smit, R Johnson, MA Van Vuuren… - Planta …, 2018 - thieme-connect.com
Rooibos, an indigenous South African plant ingested as herbal tea, is well known for its
antioxidant effects. This in vitro study investigated aspalathin (C 21 H 24 O 11), a …
antioxidant effects. This in vitro study investigated aspalathin (C 21 H 24 O 11), a …
[HTML][HTML] Salvianolic acid B attenuates apoptosis of HUVEC cells treated with high glucose or high fat via sirt1 activation
J Zhai, L Tao, Y Zhang, H Gao, X Qu, Y Song… - Evidence-Based …, 2019 - hindawi.com
High glucose and high fat are important inducements for the development and progression
of diabetic cardiopathy. Salvianolic acid B (SAB), which is the most abundant and bioactive …
of diabetic cardiopathy. Salvianolic acid B (SAB), which is the most abundant and bioactive …
[HTML][HTML] Sacubitril/valsartan combination enhanced cardiac glycophagy and prevented the progression of murine diabetic cardiomyopathy
DSA Elshenawy, NM Ramadan, VB Abdo… - Biomedicine & …, 2022 - Elsevier
Background Diabetic cardiomyopathy (DCM) is linked to disturbance in cardiac glucose
handling and increased cardiac glycogen storage. This study tested the potential role of …
handling and increased cardiac glycogen storage. This study tested the potential role of …